Biodesix (BDSX) Stock Statistics & Valuation Metrics

Biodesix has a market cap or net worth of $60.46M. The enterprise value is $92.70M.

Biodesix has 7,955,685 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biodesix’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -40.85%.

The current PE Ratio of Biodesix is ―. Biodesix’s PEG ratio is 0.10.

In the last 12 months, Biodesix had revenue of 71.32M and earned -42.93M in profits. Earnings per share was -6.60.

In the last 12 months, operating cash flow was -28.14M and capital expenditures -1.06M, giving a free cash flow of -29.20M billion.

Biodesix pays an annual dividend of ―, resulting in a dividend yield of ―

Biodesix upcoming earnings date is Mar 17, 2026, After Close (Confirmed).

Biodesix as a current ratio of 2.76, with Debt / Equity ratio of 6339.28%

In the past 12 months, Biodesix has paid 0.00 in taxes.

Biodesix EV to EBITDA ratio is -8.01, with an EV/FCF ratio of -4.51.

Biodesix has $16.60M in cash and marketable securities with $72.93M in debt, giving a net cash position of -$56.32M billion.

Gross margin is 78.77%, with operating margin of -48.37%, and net profit margin of -60.19%.

The average price target for Biodesix is $30.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy